McCormick & Company
MKC
$51.10
-0.74%
McCormick & Company is the world's leading manufacturer of spices, herbs, extracts, seasonings, and other flavorings, operating primarily in the packaged foods industry. Its portfolio includes iconic brands such as Old Bay, Zatarain's, French's, Frank's RedHot, and Cholula, and it serves both consumer and commercial (flavor solutions) markets. The company is currently at a pivotal juncture as it pursues a transformative $45 billion acquisition of Unilever's food business (including Knorr and Hellmann's), which would significantly expand its scale and diversify its product mix. Investor attention is focused on the strategic merits of this mega-deal, which promises enhanced growth in emerging markets and cost synergies, but also brings concerns about debt, integration risks, and potential dilution.…
MKC
McCormick & Company
$51.10
Related headlines
Investment Opinion: Should I buy MKC Today?
We rate MKC as a Hold. The consensus recommendation is 'Buy' with an average target of $60.62, implying 16.4% upside, but the high uncertainty surrounding the Unilever deal warrants caution. The thesis is that while the acquisition could create long-term value, the near-term risks of debt, dilution, and integration are significant, making the risk-reward balanced at current levels.
Sign up to view all
MKC 12-Month Price Forecast
The AI assessment is neutral with medium confidence. While the company's organic growth is impressive and the forward valuation appears attractive, the massive acquisition introduces significant execution risk that could derail the thesis. The stock's poor price performance suggests the market is already pricing in some negative outcomes. If the deal closes and early synergies are reported, we would upgrade to bullish. Conversely, any signs of integration trouble or a failed deal would lead to a bearish stance. The key is to monitor the deal's progress and quarterly earnings for clues.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on McCormick & Company's 12-month outlook, with a consensus price target around $60.62 and implied upside of +18.6% versus the current price.
Average Target
$60.62
0 analysts
Implied Upside
+18.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$52 - $75
Analyst target range
The price target range spans from a low of $52.00 to a high of $75.00, representing a wide spread of $23, which reflects significant uncertainty about the outcome of the Unilever deal. The low target of $52.00 is essentially at the current price, suggesting that some analysts see limited upside if integration risks materialize or if the deal fails to deliver expected synergies. The high target of $75.00 implies a 44% upside, likely assuming successful integration, cost savings, and accelerated growth in emerging markets. The wide range indicates that the market is divided on the deal's potential, and the stock's volatility is likely to remain elevated until more clarity emerges on the transaction's execution.
Bulls vs Bears: MKC Investment Factors
McCormick presents a classic high-risk, high-reward scenario. The bull case rests on strong organic growth, a forward valuation discount, and the transformative potential of the Unilever deal to create a $20B flavor giant with expanded emerging market exposure. The bear case is dominated by the sheer scale of debt and integration risk, which has already driven the stock down 25% and could lead to further downside if execution falters. Currently, the bearish evidence is stronger given the stock's persistent underperformance and the market's skepticism, but the wide analyst target range (52-75) reflects genuine uncertainty. The pivotal tension is whether management can successfully integrate Unilever's brands and deliver promised synergies without destroying shareholder value through dilution and debt overhang.
Bullish
- Strong Revenue Growth: Q2 2026 revenue grew 16.7% YoY to $1.94B, accelerating from Q1's 16.6% growth. This robust top-line performance is driven by both pricing and volume, indicating solid demand for core brands.
- Forward PE Discount to Peers: Forward PE of 15.8x is 15% below the industry average of 18.5x, suggesting the market is pricing in significant earnings growth from the Unilever acquisition. This implies potential upside if synergies materialize.
- High Analyst Target Upside: The average analyst target of $60.62 implies 16.4% upside from the current price of $52.08, while the high target of $75.00 suggests 44% upside. The consensus recommendation is 'Buy' with a mean score of 2.13.
- Resilient Dividend and Defensive Sector: With a dividend yield of 2.7% and a payout ratio of 61%, McCormick offers income stability. Its beta of 0.63 indicates lower volatility than the market, making it a defensive holding in uncertain times.
Bearish
- Massive Debt and Dilution: The $45B Unilever acquisition will significantly increase debt, with debt-to-equity already at 0.70. The deal is expected to be dilutive to earnings initially, as reflected in the wide gap between trailing PE of 22.6x and forward PE of 15.8x.
- Integration and Execution Risk: Merging Unilever's food business (Knorr, Hellmann's) poses substantial integration challenges, including cultural differences, supply chain complexities, and potential customer attrition. Historical M&A in food has often failed to deliver projected synergies.
- Stock Underperformance: MKC has fallen 25.7% over the past year, massively underperforming the S&P 500's +18.65% gain. Relative strength is deeply negative at -44.4% over 1 year, indicating persistent selling pressure and negative sentiment.
- High Valuation on Trailing Earnings: Trailing PE of 22.6x is 22% above the industry average of 18.5x, suggesting the market is paying a premium for future growth that may not materialize if the deal stumbles. This leaves little room for error.
MKC Technical Analysis
McCormick's stock has been in a pronounced downtrend over the past year, with a 1-year price change of -25.7%, significantly underperforming the S&P 500, which gained 18.65% over the same period. The current price of $52.08 sits at approximately 72% of its 52-week range (low of $44.82, high of $72.41), indicating the stock is closer to its lows than its highs. This positioning suggests that the market is pricing in substantial negative sentiment, likely due to the Unilever acquisition concerns, and the stock has yet to show signs of a sustained recovery.
Beta
0.63
0.63x market volatility
Max Drawdown
-36.9%
Largest decline past year
52-Week Range
$45-$72
Price range past year
Annual Return
-25.5%
Cumulative gain past year
| Period | MKC Return | S&P 500 |
|---|---|---|
| 1m | -3.4% | -1.6% |
| 3m | +4.4% | +2.2% |
| 6m | -12.3% | +14.4% |
| 1y | -25.5% | +16.2% |
| ytd | -24.0% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MKC Fundamental Analysis
McCormick's revenue growth has been robust, with the most recent quarter (Q2 2026) showing revenue of $1.94 billion, a 16.7% increase year-over-year. This growth is accelerating, as the previous quarter (Q1 2026) saw revenue of $1.87 billion, up from $1.61 billion in Q1 2025. The company's revenue segments show a balanced mix, with Consumer contributing $1.14 billion and Flavor Solutions $794 million in the latest quarter. This strong top-line performance is driven by both pricing and volume, and the acquisition of Unilever's food business is expected to further boost revenue, though integration risks remain.
Quarterly Revenue
$1.9B
2026-05
Revenue YoY Growth
+16.7%
YoY Comparison
Gross Margin
40.2%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MKC Overvalued?
Given that McCormick has positive net income, the PE ratio is the most appropriate valuation metric. The trailing PE stands at 22.6x, while the forward PE is 15.8x, implying that the market expects significant earnings growth, likely from the Unilever acquisition synergies and operational improvements. This gap between trailing and forward multiples suggests that investors are looking past near-term dilution and integration costs toward a more profitable future. Compared to the industry average PE of 18.5x (from valuation data), McCormick's trailing PE is at a 22% premium, but its forward PE is at a 15% discount, indicating that the market is pricing in above-average growth prospects.
PE
22.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 20x~41x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are substantial. The $45B acquisition will likely double debt levels, and with debt-to-equity already at 0.70, the company's leverage will become a major concern. Interest expenses, currently around $62.7M per quarter, could rise significantly, pressuring net income. The current ratio of 0.70 indicates potential liquidity issues, and the company's reliance on continued revenue growth to justify its forward PE of 15.8x means any slowdown could trigger multiple compression. Additionally, the wide gap between trailing and forward PE suggests the market expects a significant earnings jump, which may not materialize if integration costs exceed estimates.